The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications

Radiation Oncology

Volumn 1, Issue 1, 2006, Pages

  Zimmermann, Michel ^a   Zouhair, Abderrahim ^a   Azria, David ^b   Ozsahin, Mahmut ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

CELL CYCLE; CHEMISTRY; CLINICAL TRIAL; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; HUMAN; METABOLISM; PHYSIOLOGY; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL CYCLE; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LIGANDS; OLIGONUCLEOTIDES, ANTISENSE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TREATMENT OUTCOME;

EID: 34147178690     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-1-11     Document Type: Review

References (33)

1. Licitra L Locati LD Bossi P Head and neck cancer Ann Oncol 2004 15 Suppl 4 iv267-iv273 15477319
2. Arteaga C Targeting HER1/EGFR: A molecular approach to cancer therapy Semin Oncol 2003 30 Suppl 7 3-14
3. Baselga J Targeting the epidermal growth factor receptor: A clinical reality J Clin Oncol 2001 19 Suppl 41S-44S
4. Bonner JA Harari PM Giralt J Azarnia N Shin DM Cohen RB Jones CU Sur R Raben D Jassem J Ove R Kies MS Baselga J Youssoufian H Amellal N Rowinsky EK Ang KK Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 2006 354 567-578 10.1056/ NEJMoa053422 16467544
5. Cohen S Carpenter G King L Jr Epidermal growth factor-receptor-protein kinase interactions: Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity J Biol Chem 1980 255 4834-4842 6246084
6. Cohen S The stimulation of epidermal proliferation by a specific protein (EGF) Dev Biol 1965 12 394-407 10.1016/0012-1606(65)90005-9 5884352
7. Davies RL Grosse VA Kucherlapati R Bothwell M Genetic analysis of epidermal growth factor action: Assignment of human epidermal growth factor receptor gene to chromosome 7 Proc Natl Acad Sci 1980 77 4188-4192 349796 6254014
8. Roskoski R Jr The ErbB/HER receptor protein-tyrosine kinases and cancer Biochem Biophys Res Commun 2004 319 1-11 10.1016/j.bbrc.2004.04.150 15158434
9. Schmidt-Ullrich RK Valerie KC Chan W McWilliams D Altered expression of epidermal growth factor receptor and extrogen receptor in MCF-7 cells after single and repeated radiation exposures Int J Radiat Oncol Biol Phys 1994 29 813-819 8040028
10. Dent P Reardon DB Park JS Bowers G Logsdon C Valerie K Schmidt-Ullrich R Radiation-induced release of transforming growth factor α activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death Mol Biol Cell 1999 10 2493-2506 25480 10436007
11. Tofilon PJ Saxman S Coleman CN Molecular targets for radiation therapy: bringing preclinical data into clinical trials Clin Cancer Res 2003 9 3518-3520 14506136
12. Sartor C Mechanisms of Disease: Radiosensitization by epidermal growth factor receptor inhibitors Nat Clin Pract Oncol 2004 1 80-87 10.1038/ ncponc0048 16264825
13. Carpenter G Cohen S Epidermal growth factor Annu Rev Biochem 1979 48 193-216 10.1146/annurev.bi.48.070179.001205 382984
14. Grandis J Tweardy D Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer Cancer Res 1993 53 3579-3584 8339264
15. Grandis JR Chakraborty A Zeng Q Melhem MF Tweardy DJ Downregulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells J Cell Biochem 1998 69 55-62 10.1002/ (SICI)1097-4644(19980401)69:1<55::AID-JCB6>3.0.CO;2-U 9513046
16. Rubin Grandis J Melhem MF Barnes EL Tweardy DJ Quantitative immunohistochemical analysis of transforming growth factor α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck Cancer 1996 78 1284-1292 10.1002/ (SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X 8826952
17. Baumann M Krause M Targeting the epidermal growth factor receptor in radiotherapy: Radiobiological mechanisms, preclinical and clinical results Radiother Oncol 2004 72 257-266 10.1016/j.radonc.2004.07.007 15450723
18. Maurizi M Almadori G Ferrandina G Ferrandina G Distefano M Romanini ME Cadoni G Benedetti-Panici P Paludetti G Scambia G Mancuso S Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma Br J Cancer 1996 74 1253-1257 8883413
19. Demiral AN Sarioglu S Birlik B Sen M Kinay M Prognostic significance of EGF receptor expression in early glottic cancer Auris Nasus Larynx 31 417-424 10.1016/j.anl.2004.05.003 15571917
20. Ang KK Berkey BA Tu X Zhang HZ Katz R Hammond EH Fu KK Milas L Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 2002 62 7350-7356 12499279
21. Albanell J Codony-Servat J Rojo F Del Camp JM Sauleda S Anido J Raspall G Giralt J Rosello J Nicholson RI Mendelsohn J Baselga J Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments Cancer Res 2001 61 6500-6510 11522647
22. Hambek M Baghi M Baumaun H Strebhard K Adunka O Gstottner W Knecht R Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN) Anticancer Res 2005 25 1871-1875 16158919
23. Raben D Bianco C Milas L Ang KK Targeted therapies and radiation for the treatment of head and neck cancer: Are we making progress? Semin Radiat Oncol 2004 14 139-152 10.1053/j.semradonc.2003.12.009 15095260
24. Burtness BA Li Y Flood W Mattar BI Forastiere AA Phase III trial comparing cisplatin (C) + placebo (P) + anti-epidermal growth factor antibody (EGF-R) C225 in patients (pts) with metastatic/recurrent head and neck cancer (HNC) Proc Am Soc Clin Oncol 2002 21 226
25. Bonner JA Raisch KP Trummell HQ Robert F Meredith RB Spencer SA Buschbaum DJ Saleh MN Stackhouse MA LoBuglio AF Peters GE Carroll WR Waksal HW Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers J Clin Oncol 2000 18 Suppl 47s-53s
26. Harari PM Huang S Radiation combined with EGFR Signal Inhibitors Semin Radiat Oncol 2006 16 38-44 10.1016/j.semradonc.2005.08.005 16378905
27. Solomon B Hagekyriakou J Trivett M Stacker S McArthur G Cullinane C EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma Int J Radiat Oncol Biol Phys 2003 55 713-723 10.1016/S0360-3016(02)04357-2 12573759
28. Cohen EE Haraf DJ Stenson KM Blair E Brockstein BE Mauer AM Dekker A Williams R Lester E Vokes EE Integration of gefitinib (G) into a chemoradiation (CRT) regimen, followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC): A phase II trial J Clin Oncol 2005 23 Suppl 501s
29. Overgaard J Hansen HS Specht L Overgaard M Grau C Andersen E Bentzen J Basholt L Hansen O Johansen J Andersen L Evensen JF Five compared with six fractions per week of conventional radiotherapy of squmous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 2003 362 933-940 10.1016/S0140-6736(03)14361-9 14511925
30. Pignon JP Bourhis J Domenge C Designe L Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data Lancet 2000 355 949-955 10768432
31. Budach W Hehr T Budach V Belka C Dietz K A meta-analysis of hyperfractionated and accelerated radiotherapy and combined therapy and radiotheapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck BMC Cancer 2006 6 28 1379652 16448551 10.1186/1471-2407-6-28
32. Gorski DH Beckett MA Jasnowiak NT Calvin DP Mauceri HJ Salloum RM Seetharam S Koons A Hari DM Kufe DW Weichselbaum RR Blockade of the vascular endothelial growth factor stress response increases the the antitumor effects of ionizing radiation Cancer Res 1999 59 3374-3378 10416597
33. Sonveaux P Brouet A Havaux X Gregoire V Dessy C Balligand JL Feron O Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: Implications for tumor radiotherapy Cancer Res 2003 63 1012-1019 12615716